Initia is proud to announce that the Urological Department of Sapporo Medical University Hospital in Japan has initiated a pioneering clinical study utilizing the Renova® Low-Intensity Extracorporeal Shock Wave Therapy (Li-ESWT) protocol. This marks an important milestone in the advancement of regenerative medicine and the exploration of non-invasive treatments for erectile dysfunction (ED).

A First-of-Its-Kind Investigation

As global interest in Li-ESWT continues to grow, this study represents the first of its kind to examine the histological effects of shockwave therapy on the corpus cavernosum. The research involves volunteers undergoing penile resection as part of gender identity disorder management, offering a unique opportunity to analyze tissue-level changes.

The primary objective is to investigate how Li-ESWT promotes angiogenesis — the formation of new blood vessels — and enhances penile blood flow. These insights are expected to deepen clinical understanding of regenerative pathways and expand the therapeutic potential of Li-ESWT.

Strengthening the Evidence Base

Renova® delivers focused shockwaves to penile tissue, providing a non-invasive, drug-free option for men with ED. By contributing to this groundbreaking research, Initia reinforces its commitment to supporting scientific discovery and advancing the role of shockwave technology in modern healthcare.

Commitment to Innovation

At Initia, we remain dedicated to collaborating with leading institutions worldwide to push the boundaries of medical research. Our goal is to provide physicians with evidence-based solutions that improve patient care, expand treatment opportunities, and set new standards in non-invasive medicine.